Studying New Medicines for Children with Inflammatory Bowel Disease (IBD) After Failed Anti-TNF Treatment
Contact
Description
This study will look at how well newer medicines work and how safe they are for children and teens with inflammatory bowel disease (IBD) who did not get better with anti-TNF (anti tumor necrosis factor) treatment. Participants will answer surveys about their health for up to 36 months. We will also collect a stool sample to measure fecal calprotectin (a marker of gut inflammation) around 12 months after joining the study.
Eligibility and criteria
What to expect
We will collect information from your medical records every 3 months for up to three years. This includes things like your health history, hospital visits, surgeries, medicines, and blood test results. You'll also be asked to fill out surveys about your overall health. At the 12-month mark, we'll collect a stool sample.
Related specialties
Related conditions
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.